NYSE · IFF
International Flavors & Fragrances Inc.
$90.81+$0.15 (+0.17%)
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
Loading market information…
NASDAQ · HWKN · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Hawkins, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Hawkins, Inc.’s forward annual dividend is $0.80 per share, paid quarterly. The forward yield is 0.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Hawkins, Inc.’s next earnings report is currently expected on Jan 27, 2027, with estimated earnings per share of $0.72. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hawkins, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hawkins, Inc. is an enterprise engaged in the formulation, production, and distribution of chemicals and specialized ingredients, serving both domestic and international markets. Its operations are divided into three principal divisions: Industrial, Water Treatment, and Health and Nutrition. The Industrial division supplies industrial-grade chemicals, associated products, and services to a diverse array of sectors, including agriculture, chemical processing, electronics, energy, food production, pharmaceuticals, and plating. Key offerings encompass acids, alkaline compounds, and food-grade and pharmaceutical-quality salts and components. Furthermore, this segment manages the receipt, storage, and distribution of various bulk chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. Manufacturing activities involve sodium hypochlorite, agricultural commodities, and a range of food-grade and pharmaceutical items like liquid phosphates, lactates, and custom blends. Additionally, the segment provides repackaging services for water treatment and bulk industrial chemicals, custom chemical blending, and contract and private-label packaging for bleach products. The Water Treatment division furnishes chemicals, equipment, and tailored solutions for applications in potable water, municipal and industrial wastewater management, industrial process water, and non-residential swimming pool and agricultural water systems. The Health and Nutrition division delivers ingredient procurement, processing, and formulation services to manufacturers specializing in nutraceuticals, functional foods and beverages, personal care items, dietary supplements, and other nutritional and health & wellness products. Its product portfolio features minerals, botanicals and herbal extracts, vitamins and amino acids, excipients, joint support products, sweeteners, and enzymes. The company, established in 1938, maintains its headquarters in Roseville, Minnesota.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2026 |
|---|
| Jul 30, 2025 |
| $1.40+5.26% vs estimate |
| $293.27M+5.71% vs estimate |
| Q4 2025 | May 14, 2025 | $0.78+5.41% vs estimate | $245.32M-8.87% vs estimate |
|---|
| Q3 2025 | Jan 29, 2025 | $0.72-6.49% vs estimate | $226.21M-0.78% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
2 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 1 contributors · Median target $157.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$90.81+$0.15 (+0.17%)
International Flavors & Fragrances Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.06% below the high.
$35.40-$0.39 (-1.09%)
Element Solutions Inc’s quoted price sits in the lower half of its reported 52-week range, 28.12% below the high.
$67.93+$1.26 (+1.89%)
Eastman Chemical Company’s quoted price sits in the lower half of its reported 52-week range, 18.62% below the high.
$803.07-$70.20 (-8.04%)
NewMarket Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.19% below the high.
$170.40+$4.10 (+2.47%)
Balchem Corp’s quoted price sits in the upper half of its reported 52-week range, 7.34% below the high.
$42.88+$0.69 (+1.64%)
Avient Corporation’s quoted price sits in the upper half of its reported 52-week range, 8.06% below the high.
$74.38+$1.71 (+2.35%)
Ashland Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.95% below the high.
$75.37+$1.20 (+1.62%)
Ingevity Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.94% below the high.
